Singh Badri Nath, Achary V Mohan Murali, Panditi Varakumar, Sopory Sudhir K, Reddy Malireddy K
Crop Improvement Group, International Centre for Genetic Engineering and Biotechnology, Aruna Asaf Ali Marg, New Delhi, Delhi, 110067, India.
Waksman Institute, Rutgers, The State University of New Jersey, Piscataway, NJ, USA.
Plant Mol Biol. 2017 Aug;94(6):595-607. doi: 10.1007/s11103-017-0626-4. Epub 2017 Jun 20.
The topoisomerase II expression varies as a function of cell proliferation. Maximal topoisomerase II expression was tightly coupled to S phase and G2/M phase via both transcriptional and post-transcriptional regulation. Investigation in meiosis using pollen mother cells also revealed that it is not the major component of meiotic chromosomes, it seems to diffuse out once meiotic chromosomal condensation is completed. Synchronized tobacco BY-2 cell cultures were used to study the role of topoisomerase II in various stages of the cell cycle. Topoisomerase II transcript accumulation was observed during the S- and G2/M- phase of cell cycle. This biphasic expression pattern indicates the active requirement of topoisomerase II during these stages of the cell cycle. Through immuno-localization of topoisomerase II was observed diffusely throughout the nucleoplasm in interphase nuclei, whereas, the nucleolus region exhibited a more prominent immuno-positive staining that correlated with rRNA transcription, as shown by propidium iodide staining and BrUTP incorporation. The immuno-staining analysis also showed that topoisomerase II is the major component of mitotic chromosomes and remain attached to the chromosomes during cell division. The inhibition of topoisomerase II activity using specific inhibitors revealed quite dramatic effect on condensation of chromatin and chromosome individualization from prophase to metaphase transition. Partially condensed chromosomes were not arranged on metaphase plate and chromosomal perturbations were observed when advance to anaphase, suggesting the importance of topoisomerase II activity for proper chromosome condensation and segregation during mitosis. Contrary, topoisomerase II is not the major component of meiotic chromosomes, even though mitosis and meiosis share many processes, including the DNA replication, chromosome condensation and precisely regulated partitioning of chromosomes into daughter cells. Even if topoisomerase II is required for individualization and condensation of meiotic chromosomes, it seems to diffuse out once meiotic chromosomal condensation is completed.
拓扑异构酶II的表达随细胞增殖而变化。通过转录和转录后调控,拓扑异构酶II的最大表达与S期和G2/M期紧密相关。利用花粉母细胞进行的减数分裂研究还表明,它不是减数分裂染色体的主要成分,减数分裂染色体浓缩完成后,它似乎会扩散出去。同步化的烟草BY-2细胞培养物用于研究拓扑异构酶II在细胞周期各个阶段的作用。在细胞周期的S期和G2/M期观察到拓扑异构酶II转录本的积累。这种双相表达模式表明在细胞周期的这些阶段对拓扑异构酶II有活跃需求。通过免疫定位观察到,在间期细胞核中,拓扑异构酶II在整个核质中呈弥漫分布,而核仁区域显示出更明显的免疫阳性染色,这与rRNA转录相关,碘化丙啶染色和溴尿嘧啶三磷酸掺入显示了这一点。免疫染色分析还表明,拓扑异构酶II是有丝分裂染色体的主要成分,在细胞分裂过程中仍附着于染色体上。使用特异性抑制剂抑制拓扑异构酶II的活性,对染色质浓缩和从前期到中期转变过程中的染色体个体化有相当显著的影响。部分浓缩的染色体未排列在中期板上,进入后期时观察到染色体紊乱,这表明拓扑异构酶II的活性对于有丝分裂期间正确的染色体浓缩和分离很重要。相反,拓扑异构酶II不是减数分裂染色体的主要成分,尽管有丝分裂和减数分裂有许多共同过程,包括DNA复制、染色体浓缩以及染色体精确调控地分配到子细胞中。即使减数分裂染色体的个体化和浓缩需要拓扑异构酶II,但减数分裂染色体浓缩完成后,它似乎会扩散出去。